Task: Please answer the following question about the molecule with SMILES Nc1ccc(S(=O)(=O)[N-]c2ncccn2)cc1.[Ag+].
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Answer: Approved
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
Nc1ccc(S(=O)(=O)[N-]c2ncccn2)cc1.[Ag+]
Nc1ccc(S(=O)(=O)[N-]c2ncccn2)cc1.[Ag+]
silver;(4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Approved